Table 5.

Risk analysis of e-GFR changes.

	Univariate Beta Coefficient (Standard Error)	p-Value	Multivariate Beta Coefficient (Standard Error)	p-Value
Induction therapy (time adjusted): r-ATG/Basiliximab		0.100		0.120
Recipient age	0.05 (0.07)	0.505
BMI	−0.45 (0.25)	0.078	−0.31 (0.20)	0.124
sex: male/female	−0.59 (1.85)	0.749
DM	0.77 (1.83)	0.672
Dialysis duration	1.36 (0.60)	0.036	1.20 (0.50)	0.017
HLA 1 mismatch	−0.81 (0.78)	0.302
HLA 2 mismatch	0.14 (1.29)	0.910
PRA ≥ 50%	−1.92 (4.53)	0.671
Donor age	−0.58 (0.06)	<0.001	−0.57 (0.06)	<0.001
creatinine	−2.93 (3.00)	0.328
sex: male/female	5.86 (1.70)	0.001	1.04 (1.47)	0.478

r-ATG, rabbit anti-thymocyte globulin; BMI, body mass index; DM, diabetes mellitus; HLA, human leukocyte antigen; PRA, panel reactive antibody.